Abstract
The inconsistency of volumetric results often seen in MR neuroimaging studies can be partially attributed to small sample sizes and variable data analysis approaches. Increased sample size through multi-scanner studies can tackle the former, but combining data across different scanner platforms and field-strengths may introduce a variability factor capable of masking subtle statistical differences. To investigate the sample size effect on regression analysis between depressive symptoms and grey matter volume (GMV) loss in Alzheimer’s disease (AD), a retrospective multi-scanner investigation was conducted. A cohort of 172 AD patients, with or without comorbid depressive symptoms, was studied. Patients were scanned with different imaging protocols in four different MRI scanners operating at either 1.5 T or 3.0 T. Acquired data were uniformly analyzed using the computational anatomy toolbox (CAT12) of the statistical parametric mapping (SPM12) software. Single- and multi-scanner regression analyses were applied to identify the anatomical pattern of correlation between GM loss and depression severity. A common anatomical pattern of correlation between GMV loss and increased depression severity, mostly involving sensorimotor areas, was identified in all patient subgroups imaged in different scanners. Analysis of the pooled multi-scanner data confirmed the above finding employing a more conservative statistical criterion. In the retrospective multi-scanner setting, a significant correlation was also exhibited for temporal and frontal areas. Increasing the sample size by retrospectively pooling multi-scanner data, irrespective of the acquisition platform and parameters employed, can facilitate the identification of anatomical areas with a strong correlation between GMV changes and depression symptoms in AD patients.
Similar content being viewed by others
References
Mueller SG, Stables L, Du AT et al (2007) Measurement of hippocampal subfields and age-related changes with high resolution MRI at 4T. Neurobiol Aging 28:719–726
Jack CR Jr, Wiste HJ, Weigand SD et al (2017) Defining imaging biomarker cut points for brain aging and Alzheimer’s disease. Alzheimers Dement 13:205–216
Szentkuti A, Guderian S, Schiltz K et al (2004) Quantitative MR analyses of the hippocampus: unspecific metabolic changes in aging. J Neurol 251:1345–1353
Gonoi W, Abe O, Yamasue H et al (2010) Age-related changes in regional brain volume evaluated by atlas-based method. Neuroradiology 52:865–873
Agosta F, Galantucci S, Filippi M (2017) Advanced magnetic resonance imaging of neurodegenerative diseases. Neurol Sci 38:41–51
Wright IC, Rabe-Hesketh S, Woodruff PW, David AS, Murray RM, Bullmore ET (2000) Meta-analysis of regional brain volumes in schizophrenia. Am J Psychiatr 157:16–25
Henze R, Brunner R, Thiemann U et al (2011) Gray matter alterations in first-admission adolescents with schizophrenia. J Neuroimaging 21:241–246
Scanlon C, Ronan L, Doherty CP et al (2013) MRI-based brain structure volumes in temporal lobe epilepsy patients and their unaffected siblings: a preliminary study. J Neuroimaging 23:64–70
Chivers TR, Constantinescu CS, Tench CR (2015) MRI-based measurement of brain stem cross-sectional area in relapsing-remitting multiple sclerosis. J Neuroimaging 25:1002–1006
Retico A, Bosco P, Cerello P, Fiorina E, Chincarini A, Fantacci ME (2015) Predictive models based on support vector machines: whole-brain versus regional analysis of structural MRI in the Alzheimer’s disease. J Neuroimaging 25:552–563
Stonnington CM, Tan G, Klöppel S et al (2008) Interpreting scan data acquired from multiple scanners: a study with Alzheimer’s disease. Neuroimage 39:1180–1185
Steen RG, Hamer RM, Lieberman JA (2007) Measuring brain volume by MR imaging: impact of measurement precision and natural variation on sample size requirements. Am J Neuroradiol 28:1119–1125
Shuter B, Yeh IB, Graham S, Au C, Wang SC (2008) Reproducibility of brain tissue volumes in longitudinal studies: effects of changes in signal-to-noise ratio and scanner software. Neuroimage 41:371–379
Han X, Jovicich J, Salat D et al (2006) Reliability of MRI-derived measurements of human cerebral cortical thickness: the effects of field strength, scanner upgrade and manufacturer. Neuroimage 32:180–194
Jovicich J, Czanner S, Han X et al (2009) MRI-derived measurements of human subcortical, ventricular and intracranial brain volumes: reliability effects of scan sessions, acquisition sequences, data analyses, scanner upgrade, scanner vendors and field strengths. Neuroimage 46:177–192
Boccia M, Acierno M, Piccardi L (2015) Neuroanatomy of Alzheimer’s disease and late-life depression: a coordinate-based meta-analysis of MRI studies. J Alzheimers Dis 46:963–970
McKhann GM, Knopman DS, Chertkow H et al (2011) The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7:263–269
Burke WJ, Nitcher RL, Roccaforte WH, Wengel SP (1992) A prospective evaluation of the Geriatric Depression Scale in an outpatient geriatric assessment center. J Am Geriatr Soc 40:1227–1230
Conradsson M, Rosendahl E, Littbrand H, Gustafson Y, Olofsson B, Lovheim H (2013) Usefulness of the Geriatric Depression Scale 15-item version among very old people with and without cognitive impairment. Aging Ment Health 17:638–645
McGivney SA, Mulvihill M, Taylor B (1994) Validating the GDS depression screen in the nursing home. J Am Geriatr Soc 42:490–492
American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders, 5th edn. American Psychiatric Publishing, Arlington, VA
Yesavage JA, Brink TL, Rose TL et al (1983) Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 17:37–49
Zung WW (1965) A self-rating depression scale. Arch Gen Psychiatr 12:63–70
Mioshi E, Dawson K, Mitchell J, Arnold R, Hodges JR (2006) The Addenbrooke’s Cognitive Examination Revised (ACE-R): a brief cognitive test battery for dementia screening. Int J Geriatr Psychiatr 21:1078–1085
Dubois B, Slachevsky A, Litvan I, Pillon B (2000) The FAB: a frontal assessment battery at bedside. Neurology 55:1621–1626
Barnes J, Ridgway GR, Bartlett J et al (2010) Head size, age and gender adjustment in MRI studies: a necessary nuisance? Neuroimage 53:1244–1255
Kostić VS, Agosta F, Petrović I et al (2010) Regional patterns of brain tissue loss associated with depression in Parkinson disease. Neurology 75:857–863
Rzezak P, Squarzoni P, Duran FL et al (2015) Relationship between brain age-related reduction in gray matter and educational attainment. PLoS ONE 10:e0140945
Maldjian JA, Laurienti PJ, Burdette JB, Kraft RA (2003) An automated method for neuroanatomic and cytoarchitectonic atlas based interrogation of fMRI Data Sets. Neuroimage 19:1233–1239
Maldjian JA, Laurienti PJ, Burdette JH (2004) Precentral gyrus discrepancy in electronic versions of the Talairach Atlas. Neuroimage 21:450–455
Tzourio-Mazoyer N, Landeau B, Papathanassiou D et al (2002) Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 15:273–289
Kruggel F, Turner J, Muftuler LT (2010) Alzheimer’s Disease Neuroimaging Initiative. Impact of scanner hardware and imaging protocol on image quality and compartment volume precision in the ADNI cohort. Neuroimage. 49:2123–2133
Shokouhi M, Barnes A, Suckling J et al (2011) Assessment of the impact of the scanner-related factors on brain morphometry analysis with Brainvisa. BMC Med Imaging. 11:23
Focke NK, Helms G, Kaspar S, Diederich C, Tóth V, Dechent P, Mohr A, Paulus W (2011) Multi-site voxel-based morphometry–not quite there yet. Neuroimage. 56:1164–1170
Huppertz HJ, Kröll-Seger J, Klöppel S, Ganz RE, Kassubek J (2010) Intra- and interscanner variability of automated voxel-based volumetry based on a 3D probabilistic atlas of human cerebral structures. Neuroimage 49:2216–2224
West J, Blystad I, Engström M, Warntjes JB, Lundberg P (2013) Application of quantitative MRI for brain tissue segmentation at 1.5 T and 3.0 T field strengths. PLoS ONE 8:e74795
Chu R, Tauhid S, Glanz BI et al (2016) Whole brain volume measured from 1.5 T versus 3 T MRI in healthy subjects and patients with multiple sclerosis. J Neuroimaging 26:62–67
Tardif CL, Collins DL, Pike GB (2010) Regional impact of field strength on voxel-based morphometry results. Hum Brain Mapp 31:943–957
Brunton S, Gunasinghe C, Jones N, Kempton M, Westman E, Simmons A (2014) A voxel-wise morphometry comparison of the ADNI 1.5 T and ADNI 3.0 T volumetric protocols. Alzheimer's Demen 10(4):823
Egger K, Schocke M, Weiss E et al (2008) Pattern of brain atrophy in elderly patients with depression revealed by voxel-based morphometry. Psychiatr Res 164:237–244
Sachs-Ericsson N, Corsentino E, Moxley J et al (2013) A longitudinal study of differences in late- and early-onset geriatric depression: depressive symptoms and psychosocial, cognitive, and neurological functioning. Aging Ment Health 17:1–11
Mueller SG, Weiner MW, Thal LJ et al (2005) The Alzheimer's disease neuroimaging initiative. Neuroimaging Clin N Am 15(4):869–877
Jack CR, Bernstein MA, Fox NC et al (2008) The Alzheimer's disease neuroimaging initiative (ADNI): MRI methods. J Magn Reson Med 27:685–691
Lebedeva A, Westman E, Lebedev AV, Li X, Winblad B, Simmons A, Wahlund LO, Aarsland D (2014) Alzheimer’s Disease Neuroimaging Initiative Structural brain changes associated with depressive symptoms in the elderly with Alzheimer's disease. J Neurol Neurosurg Psychiatr 85(8):930–935
Acknowledgements
There is not any external funding source for this work and authors do not declare any potential financial conflicts-of-interest.
Funding
There is not any funding for this study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors declare that they do not have any conflict of interest.
Ethical approval
All procedures performed in this study which involved human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Karavasilis, E., Parthimos, T.P., Papatriantafyllou, J.D. et al. The power of sample size through a multi-scanner approach in MR neuroimaging regression analysis: evidence from Alzheimer’s disease with and without depression. Australas Phys Eng Sci Med 42, 563–571 (2019). https://doi.org/10.1007/s13246-019-00758-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13246-019-00758-1